Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus

Fig. 3

Frequencies of CD8-positive natural killer (NK) cells in responders (R) and non-responders (NR) assessed before treatment for all patients or for adalimumab (ADA) and etanercept (ETN) separately. Significance was determined by Welch’s corrected t test. HC healthy controls

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us